MX2019008390A - Compuestos utiles para tratar cancer. - Google Patents
Compuestos utiles para tratar cancer.Info
- Publication number
- MX2019008390A MX2019008390A MX2019008390A MX2019008390A MX2019008390A MX 2019008390 A MX2019008390 A MX 2019008390A MX 2019008390 A MX2019008390 A MX 2019008390A MX 2019008390 A MX2019008390 A MX 2019008390A MX 2019008390 A MX2019008390 A MX 2019008390A
- Authority
- MX
- Mexico
- Prior art keywords
- group
- alkyl
- treating cancer
- hydroxyl
- compounds useful
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- -1 N-methylpiperazinyl group Chemical group 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invención se refiere al compuesto (I) en donde: significa un grupo piridazina, pirirnidina o pirazina, R independientemente representa un átomo de hidrógeno, átomo de halógeno o un grupo seleccionado de entre un grupo CN, un grupo hidroxilo, un grupo COOR1, un grupo fluoroalquilo de C1-C3, un grupo fluoroalcoxi de C1-C3, un grupo NO2, un grupo NR1R2, un grupo alcoxi de C1-C4, un grupo fenoxi, y un grupo alquilo de C1-C3, el alquilo opcionalmente mono-sustituido por un grupo hidroxilo, n es 1, 2 o 3, n es 1 o 2, R es un átomo de hidrógeno, un átomo de halógeno o un grupo seleccionado entre un grupo alquilo de C1-C3, un grupo hidroxilo, un grupo COOR1, un grupo NO2, un grupo NR1R.2, un grupo morfolinilo o morfolino, un grupo N-metilpiperazinilo, un grupo fluoroalquilo de C1-C3, un grupo alcoxi de C1-C4, y un grupo CN, z es N o C, Y es N o C, X es N o C, W es N o C, T es N o C, U es N o C, para utilizarse como un agente para la prevención, inhibición o tratamiento de cáncer. Algunos de los compuestos son nuevos y también forman parte de la invención.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18654409P | 2009-06-12 | 2009-06-12 | |
| US18655209P | 2009-06-12 | 2009-06-12 | |
| EP09162630A EP2261214A1 (en) | 2009-06-12 | 2009-06-12 | Compounds useful to treat premature aging and in particular progeria |
| EP20090305540 EP2266972A1 (en) | 2009-06-12 | 2009-06-12 | New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019008390A true MX2019008390A (es) | 2019-09-09 |
Family
ID=56384060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019008390A MX2019008390A (es) | 2009-06-12 | 2011-12-07 | Compuestos utiles para tratar cancer. |
Country Status (3)
| Country | Link |
|---|---|
| JP (11) | JP6150445B2 (es) |
| HR (1) | HRP20191460T1 (es) |
| MX (1) | MX2019008390A (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010143169A2 (en) * | 2009-06-12 | 2010-12-16 | Société Splicos | Compounds useful for treating aids |
| HRP20191460T1 (hr) * | 2009-06-12 | 2019-11-15 | Abivax | Spojevi korisni za liječenje raka |
| US10253020B2 (en) | 2009-06-12 | 2019-04-09 | Abivax | Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging |
| EP2757161A1 (en) | 2013-01-17 | 2014-07-23 | Splicos | miRNA-124 as a biomarker of viral infection |
| EP2974729A1 (en) | 2014-07-17 | 2016-01-20 | Abivax | Quinoline derivatives for use in the treatment of inflammatory diseases |
| EP3669873A1 (en) | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use ine the traeatment of inflammation diseases |
| CN118591528A (zh) * | 2022-01-24 | 2024-09-03 | 江苏恒瑞医药股份有限公司 | 喹啉胺类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE958647C (de) * | 1952-12-28 | 1957-02-21 | Hoechst Ag | Verfahren zur Herstellung von 7-Amino-2-oxy-4-methyl-chinolinen |
| US6177401B1 (en) * | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| WO2002074726A2 (en) * | 2001-01-22 | 2002-09-26 | Memory Pharmaceuticals Corporation | Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| AU2002950217A0 (en) * | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
| FR2912745A1 (fr) * | 2007-02-19 | 2008-08-22 | Centre Nat Rech Scient | Nouveaux composes derives d'indole et compositions pharmaceutiques les contenant |
| CA2681481A1 (en) * | 2007-03-16 | 2008-09-25 | Mount Sinai School Of Medicine | Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction |
| WO2010143169A2 (en) * | 2009-06-12 | 2010-12-16 | Société Splicos | Compounds useful for treating aids |
| HRP20191460T1 (hr) * | 2009-06-12 | 2019-11-15 | Abivax | Spojevi korisni za liječenje raka |
-
2010
- 2010-06-14 HR HRP20191460 patent/HRP20191460T1/hr unknown
-
2011
- 2011-12-07 MX MX2019008390A patent/MX2019008390A/es unknown
-
2016
- 2016-01-15 JP JP2016006105A patent/JP6150445B2/ja active Active
- 2016-01-15 JP JP2016006102A patent/JP6149128B2/ja active Active
- 2016-01-15 JP JP2016006104A patent/JP6149129B2/ja active Active
- 2016-01-15 JP JP2016006101A patent/JP6149127B2/ja active Active
- 2016-01-15 JP JP2016006103A patent/JP6154922B2/ja active Active
-
2017
- 2017-03-31 JP JP2017070251A patent/JP6419243B2/ja active Active
- 2017-03-31 JP JP2017071704A patent/JP6336650B2/ja active Active
- 2017-05-22 JP JP2017101011A patent/JP6378802B2/ja active Active
-
2018
- 2018-06-25 JP JP2018119763A patent/JP2018162292A/ja not_active Withdrawn
- 2018-06-25 JP JP2018119762A patent/JP6606577B2/ja active Active
- 2018-06-25 JP JP2018119761A patent/JP6694476B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016147850A (ja) | 2016-08-18 |
| JP2017137341A (ja) | 2017-08-10 |
| JP2018162291A (ja) | 2018-10-18 |
| HRP20191460T1 (hr) | 2019-11-15 |
| JP2017137342A (ja) | 2017-08-10 |
| JP6336650B2 (ja) | 2018-06-06 |
| JP2016128461A (ja) | 2016-07-14 |
| JP6149128B2 (ja) | 2017-06-14 |
| JP2018162290A (ja) | 2018-10-18 |
| JP2017222639A (ja) | 2017-12-21 |
| JP6419243B2 (ja) | 2018-11-07 |
| JP6149129B2 (ja) | 2017-06-14 |
| JP2016128462A (ja) | 2016-07-14 |
| JP6154922B2 (ja) | 2017-06-28 |
| JP2016128463A (ja) | 2016-07-14 |
| JP6694476B2 (ja) | 2020-05-13 |
| JP6150445B2 (ja) | 2017-06-21 |
| JP6149127B2 (ja) | 2017-06-14 |
| JP2016135776A (ja) | 2016-07-28 |
| JP6378802B2 (ja) | 2018-08-22 |
| JP6606577B2 (ja) | 2019-11-13 |
| JP2018162292A (ja) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX367601B (es) | Compuestos útiles para tratar cáncer. | |
| MX2019008390A (es) | Compuestos utiles para tratar cancer. | |
| TW200611907A (en) | Fused heterocyclic compound | |
| PH12014502420A1 (en) | Iap bir domain binding compound | |
| TNSN07281A1 (en) | Pyrazole derivatives for the inhibition of cdk's and gsk's | |
| TW200641539A (en) | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | |
| NI200900164A (es) | COMPUESTOS AMINO- 5 -[ -4- (DIFLUOROMETOXI) FENIL SUSTITUIDO] -5- FENILIMIDAZOLONA COMO INHIBIDORES DE Beta - SECRETASA. | |
| NZ587051A (en) | Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase) | |
| TN2014000003A1 (en) | Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds | |
| PT2173173E (pt) | Derivados 6-anilinopurina substituída como inibidores da citoquinina oxidase/desidrogenase e preparações contendo estes derivados | |
| GEP20115171B (en) | Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor | |
| MX2015017599A (es) | Compuestos biciclicos utiles para el tratamiento de enfermedades causadas por retrovirus. | |
| MX342377B (es) | Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico. | |
| MX2014001669A (es) | Compuestos de fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-feni l]-2-alcoxi-2-alquinil/alquenil-etil}-1h-[1,2,4]triazol sustituidos. | |
| MX348867B (es) | Compuestos quimicos. | |
| WO2006124511A3 (en) | Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth | |
| MX2009009858A (es) | Proceso e intermediarios para preparar arzoxifeno. | |
| PL391681A1 (pl) | Sposób otrzymywania pochodnych chinolinotiosemikarbazonu oraz ich zastosowanie | |
| MX2012006897A (es) | Compuestos heterociclicos como inhibidores de janus cinasa. | |
| WO2008105473A1 (ja) | 抗悪性腫瘍薬 | |
| MX2014007398A (es) | Derivado de 2,4-diamina-pirimidina como inhibidores de serina/treonina quinasa. | |
| TW200637858A (en) | Pharmaceutical compounds |